Alnylam Pharmaceuticals
ALNY
#1096
Rank
โ‚น2.029 T
Marketcap
โ‚น15,156
Share price
1.20%
Change (1 day)
-60.65%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company